Evidence map›Paper›PMID 27405273›Full record

ArticleEuropean journal of immunology2016

Clathrin regulates lymphocyte migration by driving actin accumulation at the cellular leading edge.

Guillermo Ramírez-Santiago, Javier Robles-Valero, Giulia Morlino, Aranzazu Cruz-Adalia, Manuel Pérez-Martínez, Airen Zaldivar, Mónica Torres-Torresano, Francisco Javier Chichón, Andrea Sorrentino, Eva Pereiro and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Guillermo Ramírez-SantiagoCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Department of Molecular & Cellular Biology, Madrid, Spain.
Javier Robles-ValeroInstituto de Investigación Sanitaria Princesa, Hospital de la Princesa, Madrid, Spain.
Giulia MorlinoInstituto de Investigación Sanitaria Princesa, Hospital de la Princesa, Madrid, Spain.
Aranzazu Cruz-AdaliaCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Department of Molecular & Cellular Biology, Madrid, Spain.
Manuel Pérez-MartínezCentro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Airen ZaldivarCentro Nacional de Biotecnología (CNB-CSIC), Department of Macromolecular Structures, Madrid, Spain.
Mónica Torres-TorresanoCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Department of Molecular & Cellular Biology, Madrid, Spain.
Francisco Javier ChichónCentro Nacional de Biotecnología (CNB-CSIC), Department of Macromolecular Structures, Madrid, Spain.
Andrea SorrentinoALBA Synchrotron Light Source, MISTRAL Beamline-Experiments Division, Cerdanyola del Vallès, Barcelona, Spain.
Eva PereiroALBA Synchrotron Light Source, MISTRAL Beamline-Experiments Division, Cerdanyola del Vallès, Barcelona, Spain.
José L CarrascosaCentro Nacional de Biotecnología (CNB-CSIC), Department of Macromolecular Structures, Madrid, Spain.
Diego MegíasCentro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Carlos Oscar S SorzanoCentro Nacional de Biotecnología (CNB-CSIC), Department of Macromolecular Structures, Madrid, Spain.
Francisco Sánchez-MadridInstituto de Investigación Sanitaria Princesa, Hospital de la Princesa, Madrid, Spain.
Esteban VeigaCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Department of Molecular & Cellular Biology, Madrid, Spain. eveiga@cnb.csic.es.
Centro Nacional de Biotecnología · ESHospital Universitario de La Princesa · ESALBA Synchrotron (Spain) · ESCentro Nacional de Epidemiología · ESConsejo Superior de Investigaciones Científicas · ESHospital Universitario Santa Cristina · ES

Funding

European Research Council 294340
6 · The paper itself

Abstract

Lymphocyte migration, which is essential for effective immune responses, belongs to the so-called amoeboid migration. The lymphocyte migration is up to 100 times faster than between mesenchymal and epithelial cell types. Migrating lymphocytes are highly polarized in three well-defined structural and functional zones: uropod, medial zone, and leading edge (LE). The actiomyosin-dependent driving force moves forward the uropod, whereas massive actin rearrangements protruding the cell membrane are observed at the LE. These actin rearrangements resemble those observed at the immunological synapse driven by clathrin, a protein normally involved in endocytic processes. Here, we used cell lines as well as primary lymphocytes to demonstrate that clathrin and clathrin adaptors colocalize with actin at the LE of migrating lymphocytes, but not in other cellular zones that accumulate both clathrin and actin. Moreover, clathrin and clathrin adaptors, including Hrs, the clathrin adaptor for multivesicular bodies, drive local actin accumulation at the LE. Clathrin recruitment at the LE resulted necessary for a complete cell polarization and further lymphocyte migration in both 2D and 3D migration models. Therefore, clathrin, including the clathrin population associated to internal vesicles, controls lymphocyte migration by regulating actin rearrangements occurring at the LE.

Indexed as

Cell MovementActinsCell PolarityClathrinEndosomal Sorting Complexes Required for TransportHumansImmunological SynapsesJurkat CellsPhosphoproteinsProtein TransportRNA, Small InterferingT-LymphocytesTransport VesiclesActinsClathrinEndosomal Sorting Complexes Required for Transporthepatocyte growth factor-regulated tyrosine kinase substratePhosphoproteinsRNA, Small InterferingCellular immunologyCytoskeletonLymphocyte migration

Identifiers

PMID27405273
PMCPMC6485598
OpenAlexW2460471344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.